Lactobacillus casei Shirota supplementation does not restore gut microbiota composition and gut barrier in metabolic syndrome: A randomized pilot study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Stadlbauer, Vanessa ^a   Leber, Bettina ^a   Lemesch, Sandra ^a   Trajanoski, Slave ^b   Bashir, Mina ^a   Horvath, Angela ^a   Tawdrous, Monika ^a   Stojakovic, Tatjana ^a   Fauler, Günter ^a   Fickert, Peter ^a   Högenauer, Christoph ^a   Klymiuk, Ingeborg ^b   Stiegler, Philipp ^a   Lamprecht, Manfred ^a   Pieber, Thomas R ^a,c   Tripolt, Norbert J ^a,c   Sourij, Harald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Center for Medical Research   (Austria)

^c Centre for Biomarker Research in Medicine (CBmed)   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CALGRANULIN; MEMBRANE PROTEIN; RNA 16S; UNCLASSIFIED DRUG; ZONULIN; BIOLOGICAL MARKER; PROBIOTIC AGENT;

ADULT; ARTICLE; BACTEROIDETES; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA ISOLATION; DNA SEQUENCE; ENRICHMENT CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FIRMICUTES; FOOD FREQUENCY QUESTIONNAIRE; GENE SEQUENCE; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS CASEI; MALE; MEMBRANE PERMEABILITY; METABOLIC SYNDROME X; PHYLOGENETIC TREE; PILOT STUDY; PROSPECTIVE STUDY; PYROSEQUENCING; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; SYSTOLIC BLOOD PRESSURE; TAXONOMY; AGED; BIODIVERSITY; CASE CONTROL STUDY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; BILE ACIDS AND SALTS; BIODIVERSITY; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS;

EID: 84949681474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141399     Document Type: Article

References (69)

1. WHO. Obesity and overweight. Fact sheet. 2014;131.
2. Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM, et al. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clinical endocrinology. 2007; 66(5):666-71. doi: 10.1111/j.1365-2265.2007.02798.x PMID: 17381490.
3. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669):1083-96. doi: 10.1016/S0140-6736(09)60318-4 PMID: 19299006; PubMed Central PMCID: PMC2662372.
4. Esteve E, Ricart W, Fernandez-Real JM. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Current opinion in clinical nutrition and metabolic care. 2011; 14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d PMID: 21681087.
5. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102(31):11070-5. PMID: 16033867.
6. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005; 307(5717):1915-20. PMID: 15790844.
7. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond). 2008; 32(11):1720-4. Epub 2008/09/10. doi: 10.1038/ijo.2008.155 ijo2008155 [pii]. PMID: 18779823.
8. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010; 18(1):190-5. Epub 2009/06/06. doi: 10.1038/oby.2009.167 oby2009167 [pii]. PMID: 19498350.
9. Zupancic ML, Cantarel BL, Liu Z, Drabek EF, Ryan KA, Cirimotich S, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One. 2012; 7(8):e43052. Epub 2012/08/21. doi: 10.1371/journal.pone.0043052 PONE-D-11-23689 [pii]. PMID: 22905200; PubMed Central PMCID: PMC3419686.
10. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009; 106(7):2365-70. Epub 2009/01/24. doi: 10. 1073/pnas.0812600106 0812600106 [pii]. PMID: 19164560; PubMed Central PMCID: PMC2629490.
11. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American journal of physiologyEndocrinology and metabolism. 2007; 292(3):E740-7. doi: 10.1152/ajpendo.00302.2006
12. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010; 5(2): e9085. doi: 10.1371/journal.pone.0009085 PMID: 20140211; PubMed Central PMCID: PMC2816710.
13. Stenman LK, Holma R, Eggert A, Korpela R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol. 2013; 304 (3):G227-34. Epub 2012/12/04. doi: 10.1152/ajpgi.00267.2012 ajpgi.00267.2012 [pii]. PMID: 23203158.
14. Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol. 2012; 18(9):923-9. Epub 2012/03/13. doi: 10.3748/wjg. v18.i9.923 PMID: 22408351; PubMed Central PMCID: PMC3297051.
15. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Current pharmaceutical design. 2009; 15(13):1546-58. PMID: 19442172.
16. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Current opinion in pharmacology. 2009; 9(6):737-43. doi: 10.1016/j.coph.2009. 06.016 PMID: 19628432.
17. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. doi: 10.2337/db07-1403 PMID: 18305141
18. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, et al. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol. 2011; 110(3):650-7. doi: 10.1111/j.1365-2672.2010.04922.x PMID: 21281408
19. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RM, Moller K, Svendsen KD, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr. 2010; 104(12):1831-8. doi: 10.1017/S0007114510002874 PMID: 20815975.
20. Leber B, Tripolt NJ, Blattl D, Eder M, Wascher TC, Pieber TR, et al. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr. 2012; 66(10):1110-5. doi: 10.1038/ejcn.2012.103 PMID: 22872030.
21. Tripolt NJ, Leber B, Blattl D, Eder M, Wonisch W, Scharnagl H, et al. Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome-A pilot study. J Dairy Sci. 2012. Epub 2012/11/21. S0022-0302(12)00847-8 [pii] doi: 10.3168/jds.2012-5863 PMID: 23164226.
22. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16):1640-5. doi: 10.1161/circulationaha.109.192644 PMID: 19805654
23. Baker GC, Smith JJ, Cowan DA. Review and re-analysis of domain-specific 16S primers. J Microbiol Methods. 2003; 55(3):541-55. PMID: 14607398.
24. Watanabe K, Kodama Y, Harayama S. Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting. J Microbiol Methods. 2001; 44(3):253-62. PMID: 11240048.
25. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflammatory bowel diseases. 2013; 19(10):2155-65. doi: 10.1097/MIB. 0b013e31829ea325 PMID: 23899544.
26. Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V, et al. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007; 46(3):776-84. Epub 2007/08/03. doi: 10.1002/hep.21741 PMID: 17668874.
27. Huse SM, Welch DM, Morrison HG, Sogin ML. Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ Microbiol. 2010; 12(7):1889-98. doi: 10.1111/j.1462-2920.2010. 02193.x PMID: 20236171; PubMed Central PMCID: PMC2909393.
28. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010; 7(5):335-6. doi: 1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
29. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26 (19):2460-1. doi: 10.1093/bioinformatics/btq461 PMID: 20709691.
30. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73(16):5261-7. doi: 1128/AEM.00062-07 PMID: 17586664; PubMed Central PMCID: PMC1950982.
31. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012; 6(3):610-8. doi: 10.1038/ismej.2011.139 PMID: 22134646; PubMed Central PMCID: PMC3280142.
32. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2010; 26(2):266-7. doi: 10.1093/bioinformatics/btp636 PMID: 19914921; PubMed Central PMCID: PMC2804299.
33. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome research. 2011; 21(3):494-504. doi: 10.1101/gr.112730.110 PMID: 21212162; PubMed Central PMCID: PMC3044863.
34. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One. 2010; 5(3):e9490. doi: 10.1371/journal.pone.0009490 PMID: 20224823; PubMed Central PMCID: PMC2835736.
35. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007; 104(3):979-84. doi: 10.1073/pnas.0605374104 PMID: 17210919
36. Ley RE. Obesity and the human microbiome. Current opinion in gastroenterology. 2010; 26(1):5-11. doi: 10.1097/MOG.0b013e328333d751 PMID: 19901833
37. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. The Journal of clinical investigation. 2011; 121(6):2126-32. doi: 10.1172/jci58109; 10.1172/jci58109 PMID: 21633181
38. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012; 489(7415):242-9. doi: 10.1038/nature11552 PMID: 22972297.
39. Parekh PJ, Arusi E, Vinik AI, Johnson DA. The Role and Influence of Gut Microbiota in Pathogenesis and Management of Obesity and Metabolic Syndrome. Front Endocrinol (Lausanne). 2014; 5:47. Epub 2014/04/30. doi: 10.3389/fendo.2014.00047 PMID: 24778627.
40. Roager HM, Licht TR, Poulsen SK, Larsen TM, Bahl MI. Microbial enterotypes, inferred by the prevotella- to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. Appl Environ Microbiol. 2014; 80(3):1142-9. doi: 10.1128/AEM.03549-13 PMID: 24296500; PubMed Central PMCID: PMC3911217.
41. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490(7418):55-60. doi: 10.1038/nature11450 PMID: 23023125.
42. Fukuda S, Ohno H. Gut microbiome and metabolic diseases. Seminars in immunopathology. 2014; 36 (1):103-14. doi: 10.1007/s00281-013-0399-z PMID: 24196453.
43. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102(31):11070-5. doi: 10.1073/pnas.0504978102 PMID: 16033867
44. Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One. 2010; 5(11):e15046. doi: 10.1371/journal.pone.0015046 PMID: 21151493; PubMed Central PMCID: PMC2993935.
45. De Cruz P, Kang S, Wagner J, Buckley M, Sim WH, Prideaux L, et al. Specific Mucosa-Associated Microbiota in Crohn's Disease at the Time of Resection are Associated with Early Disease Recurrence: A Pilot Study. Journal of gastroenterology and hepatology. 2014. doi: 10.1111/jgh.12694
46. Wong VW, Tse CH, Lam TT, Wong GL, Chim AM, Chu WC, et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-a longitudinal study. PLoS One. 2013; 8 (4):e62885. doi: 10.1371/journal.pone.0062885 PMID: 23638162; PubMed Central PMCID: PMC3636208.
47. Shirota M, Aso K, Iwabuchi A. Studies on intestinal microflora. 1. Its constitution in healthy infants and the effect of oral administration of L. acidophilus strain Shirota. Nippon saikingaku zasshiJapanese journal of bacteriology. 1966; 21(5):274-83.
48. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998; 52(12):899-907. PMID: 9881885
49. Tuohy KM, Pinart-Gilberga M, Jones M, Hoyles L, McCartney AL, Gibson GR. Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol. 2007; 102(4):1026-32. doi: 10.1111/j.1365-2672.2006.03154.x PMID: 17381746
50. Takeda K, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. The Journal of nutrition. 2007; 137(3 Suppl 2):791S-3S. PMID: 17311976
51. Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008; 48(6):945-51. doi: 10.1016/j.jhep.2008.02.015 PMID: 18433921
52. Tiengrim S, Leelaporn A, Manatsathit S, Thamlikitkul V. Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012; 95 Suppl 2:S42-7. Epub 2012/05/12. PMID: 22574528.
53. Yuki N, Watanabe K, Mike A, Tagami Y, Tanaka R, Ohwaki M, et al. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. International journal of food microbiology. 1999; 48(1):51-7. Epub 1999/06/22. PMID: 10375134.
54. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. International journal of food microbiology. 2008; 126(1-2):210-5. doi: 10.1016/j. ijfoodmicro.2008.05.022 PMID: 18573558.
55. Sakai T, Oishi K, Asahara T, Takada T, Yuki N, Matsumoto K, et al. M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus. International journal of food microbiology. 2010; 139(3):154-60. doi: 10.1016/j.ijfoodmicro.2010.03.019 PMID: 20385416.
56. Tilley L, Keppens K, Kushiro A, Takada T, Sakai T, Vaneechoutte M, et al. A probiotic fermented milk drink containing Lactobacillus cassei strain Shirota improves stool consistency of subjects with hard stools. International Journal of Probiotics and Prebiotics. 2014; 9(1-2):23-30.
57. Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci. 2000; 915:214-22. Epub 2001/02/24. PMID: 11193578.
58. Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000; 113 Pt 24:4435-40. Epub 2000/11/18. PMID: 11082037.
59. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000; 355(9214):1518-9. Epub 2000/05/09. S0140-6736(00)02169-3 [pii] doi: 10.1016/S0140-6736(00)02169-3 PMID: 10801176.
60. Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012; 7(5):e37160. Epub 2012/05/26. doi: 10.1371/journal.pone.0037160 PONE-D-12-01867 [pii]. PMID: 22629362; PubMed Central PMCID: PMC3356365.
61. Goodrich KM, Fundaro G, Griffin LE, Grant A, Hulver MW, Ponder MA, et al. Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin: a secondary analysis of healthy Wistar Furth rats. Nutr Res. 2012; 32 (10):787-94. Epub 2012/11/14. doi: 10.1016/j.nutres.2012.09.004 S0271-5317(12)00186-8 [pii]. PMID: 23146776.
62. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013; 143(3):324-31. Epub 2013/01/11. doi: 10.3945/jn.112.166132 jn.112.166132 [pii]. PMID: 23303873.
63. Raimondi F, Santoro P, Barone MV, Pappacoda S, Barretta ML, Nanayakkara M, et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. Am J Physiol Gastrointest Liver Physiol. 2008; 294(4):G906-13. Epub 2008/02/02. doi: 10.1152/ajpgi.00043. 2007 PMID: 18239063.
64. Stenman LK, Holma R, Gylling H, Korpela R. Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr. 2013; 110(6):1157-64. Epub 2013/02/28. doi: 10. 1017/S000711451300024X PMID: 23442231.
65. Liaset B, Hao Q, Jorgensen H, Hallenborg P, Du ZY, Ma T, et al. Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome. The Journal of biological chemistry. 2011; 286(32):28382-95. Epub 2011/06/18. doi: 10.1074/jbc.M111. 234732 PMID: 21680746; PubMed Central PMCID: PMC3151081.
66. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. The Journal of biological chemistry. 2011; 286(30):26913-20. Epub 2011/06/03. doi: 10.1074/jbc.M111.248203 PMID: 21632533; PubMed Central PMCID: PMC3143650.
67. Steiner C, Othman A, Saely CH, Rein P, Drexel H, von Eckardstein A, et al. Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. PLoS One. 2011; 6(11):e25006. Epub 2011/11/24. doi: 10.1371/journal.pone.0025006 PMID: 22110577; PubMed Central PMCID: PMC3215718.
68. Voreades N, Kozil A, Weir TL. Diet and the development of the human intestinal microbiome. Frontiers in microbiology. 2014; 5:494. doi: 10.3389/fmicb.2014.00494 PMID: 25295033; PubMed Central PMCID: PMC4170138.
69. Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009; 9:123. doi: 10.1186/1471-2180-9-123 PMID: 19508720; PubMed Central PMCID: PMC2702274.